LPCAT1 and pulmonary emphysema: Lysophosphatidylcholine acyltransferase 1 (LPCAT1) and its protein product have been extensively investigated for their potential role in various lung diseases, including emphysema, fibrosis, pneumonia, and neonatal respiratory distress syndrome [13–16].